Skip to content

Idexx Laboratories IDXX Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Zoetis logo
ZoetisZTS
Abbott logo
AbbottABT
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's treasury stock, shares (in shares)?
Idexx Laboratories (IDXX) reported treasury stock, shares (in shares) of $29.26M in Q1 2026.
How has Idexx Laboratories's treasury stock, shares (in shares) changed year-over-year?
Idexx Laboratories's treasury stock, shares (in shares) increased by 7.7% year-over-year, from $27.18M to $29.26M.
What is the long-term trend for Idexx Laboratories's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Idexx Laboratories's treasury stock, shares (in shares) has grown at a 6.5% compound annual growth rate (CAGR), from $22.32M to $28.66M.